Dr. Martin Gleave
Distinguished Professor and Chair, Department of Urologic Sciences at UBC, and British Columbia Leadership Chair.
Director of the Vancouver Prostate Centre.
Age 60 (Diagnosed with advanced prostate cancer at 48)
The PSMA PET scan is making differences along the spectrum of the disease. It’s going to be used in men with high-risk localized prostate cancer, prior to surgery or radiation, to identify early spread that we cannot see with bone scans and CT scans.
To learn more about prostate cancer biomarkers please speak with your healthcare provider.
Made possible through financial support from one of the Canada’s leading research-based pharmaceutical companies.